Re: Ming Yuen Teo, Jose Mauricio Mota, Karissa A. Whiting, et al. Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma. Eur Urol 2020;78:907-15: Linking FGFR3 Mutation Status and Luminal Papillary Subtype to Response to Cisplatin-based Chemotherapy in Bladder Cancer.
作者信息
Roumiguie Mathieu, Contreras-Sanz Alberto, Black Peter C
机构信息
Department of Urology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
出版信息
Eur Urol. 2021 Jun;79(6):e182-e183. doi: 10.1016/j.eururo.2021.03.028. Epub 2021 Apr 8.
PMID:33838962
Abstract
摘要
Zotero 插件